搜索临床试验以:DA-9801 300毫克
总计2030个结果
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.完全的
-
Ifakara Health InstituteUniversity of Oxford尚未招聘
-
Leap Therapeutics, Inc.BeiGene主动,不招人
-
Massachusetts General HospitalMerck Sharp & Dohme LLC完全的
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...招聘中
-
Fuji Yakuhin Co., Ltd.Mochida Pharmaceutical Company, Ltd.完全的
-
Genzyme, a Sanofi Company完全的
-
Lihir Medical CentreUniversity of Washington; World Health Organization; Barcelona Institute for Global Health; National...完全的
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales Servier尚未招聘具有 IDH1 突变、未经治疗或之前接受过 1 种全身治疗方案治疗的局部晚期或转移性传统软骨肉瘤
-
University of Patras完全的
-
Urovant Sciences GmbH完全的
-
Hellenic Oncology Research Group终止
-
Oncternal Therapeutics, IncUniversity of California, San Diego; Pharmacyclics LLC.; California Institute for Regenerative...主动,不招人
-
Chinese PLA General HospitalTianjin TongRenTang Group Co., Ltd.未知
-
University of SurreyRoyal Surrey County Hospital NHS Foundation Trust完全的
-
Seoul National University HospitalSeoul National University Bundang Hospital; Dong-A Pharmaceutical Co., Ltd.未知
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; Qilu Hospital of Shandong University; First Hospital of China Medical University 和其他合作者招聘中
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.完全的
-
Norwegian University of Science and TechnologySt. Olavs Hospital完全的
-
Medical Research Council Unit, The Gambia完全的
-
Chong Kun Dang PharmaceuticalCholine Alfoscerate Re-evaluation Consortium (57 pharmaceutical companies)尚未招聘
-
ViiV HealthcareGlaxoSmithKline; Shionogi完全的
-
Sir Mortimer B. Davis - Jewish General HospitalCancer Research Network终止